← Back to Clinical Trials
Recruiting NCT04666402

Integrated Diagnostics for Early Diagnosis of Liver Disease

Trial Parameters

Condition Non-Alcoholic Fatty Liver Disease
Sponsor Manchester University NHS Foundation Trust
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2020-10-21
Completion 2027-03-31
Interventions
Blood tests for Single Nucleotide PolymorphismsFaecal microbiome analysisSerum for diagnostic biomarkers

Brief Summary

This is an observational study that will explore the hypothesis that by combining data from patients with liver disease with novel blood biomarkers, single nucleotide polymorphism (SNP) analysis and faecal microbiome analysis. The Investigators will improve diagnosis of liver fibrosis compared to the current available diagnostic tools.

Eligibility Criteria

Inclusion Criteria: * All patients referred to Community Liver Assessment Clinic. * Male or female \> 18 years of age. * Females will be non-pregnant and non-lactating. Exclusion Criteria: * Age \< 18 years. * Pregnancy/breast-feeding. Women of childbearing potential (not \>2 years post- menopausal and/or not surgically sterilised) must have a negative blood serum pregnancy test. * Isolated bilirubinaemia. * Known pre-existing liver disease. * Acutely unwell. * Suspected malignancy.

Related Trials